Abbvie (ABBV) Financials
Abbvie (ABBV) Historical Financial Statements and Key Metrics for 2011 - 2021
Full Abbvie financials for 2011 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbvie Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Jun-30 | 13,959 | 9,436 (67.6 %) | 4,538 (8.3 %) | 766 (5.5 %) | 3,975 | 0.42 |
| 2021-Mar-31 | 13,010 | 8,797 (67.6 %) | 4,173 (32.1 %) | 3,553 (27.3 %) | 6,388 | 1.99 |
| 2020-Dec-31 | 13,858 | 9,174 (66.2 %) | 4,053 (29.2 %) | 36 (0.3 %) | 6,118 | 0.02 |
| 2020-Sep-30 | 12,902 | 7,852 (60.9 %) | 3,255 (25.2 %) | 2,308 (17.9 %) | 5,547 | 1.29 |
| 2020-Jun-30 | 10,425 | 6,714 (64.4 %) | 752 (7.2 %) | -738 (-7.1 %) | 2,307 | -0.46 |
| 2020-Mar-31 | 8,619 | 6,677 (77.5 %) | 3,603 (41.8 %) | 3,010 (34.9 %) | 4,162 | 2.02 |
| 2019-Dec-31 | 8,704 | 6,698 (77.0 %) | 3,956 (45.5 %) | 2,801 (32.2 %) | 4,465 | 1.88 |
Full historical income statements for 2011 - 2021 is included in the
US Historical Financials dataset.
Abbvie Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Jun-30 | 147,972 | 135,378 | 82,138 | 12,594 | 8,600 |
| 2021-Mar-31 | 150,501 | 136,768 | 85,530 | 13,710 | 9,777 |
| 2020-Dec-31 | 150,565 | 137,468 | 86,056 | 13,097 | 8,479 |
| 2020-Sep-30 | 149,621 | 134,332 | 87,059 | 15,289 | 7,950 |
| 2020-Jun-30 | 149,530 | 134,798 | 87,432 | 14,732 | 6,040 |
| 2020-Mar-31 | 91,199 | 98,614 | 67,046 | -7,415 | 41,142 |
| 2019-Dec-31 | 89,115 | 97,287 | 66,728 | -8,172 | 39,924 |
Full historical balance sheet data for 2011 - 2021 is included in the
US Historical Financials dataset.
Abbvie Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Jun-30 | 4,890 | -242 | -5,884 | 4,695 |
| 2021-Mar-31 | 4,877 | -342 | -3,174 | 4,689 |
| 2020-Dec-31 | 4,854 | -627 | -3,695 | 4,575 |
| 2020-Sep-30 | 5,830 | -1,149 | -2,814 | 5,613 |
| 2020-Jun-30 | 3,089 | -35,652 | -2,570 | 2,912 |
| 2020-Mar-31 | 3,815 | -129 | -2,422 | 3,690 |
| 2019-Dec-31 | 3,275 | -615 | 26,602 | 3,112 |
Full historical cash flow data for 2011 - 2021 is included in the
US Historical Financials dataset.
Abbvie Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Jun-30 | 199,260 | 272,852 | 14.27 | 65.03 | 15.82 |
| 2021-Mar-31 | 191,441 | 267,216 | 14.71 | 13.47 | 13.96 |
| 2020-Dec-31 | 189,151 | 266,758 | 13.65 | 1,313.55 | 14.44 |
| 2020-Sep-30 | 154,622 | 233,791 | 11.98 | 16.75 | 10.11 |
| 2020-Jun-30 | 173,217 | 254,632 | 16.62 | -58.68 | 11.76 |
| 2020-Mar-31 | 112,508 | 138,412 | 13.05 | 9.34 | -15.17 |
| 2019-Dec-31 | 130,943 | 157,747 | 15.04 | 11.69 | -16.02 |
Full historical valuation and operating metrics for 2011 - 2021 are included in the
US Historical Financials dataset.